Totally Implantable Central Venous Access Port-Associated Bloodstream Infection Caused by Corynebacterium provencense: The First Case Report

<i>Corynebacterium</i> species are associated with healthcare-associated infections, specifically in device implantation. Here, we report a rare case of a 44-year-old man with a totally implantable central venous access port-related <i>Corynebacterium</i> infection. When he developed a fever on day four of admission, vancomycin treatment was initiated. On the 11th day, the totally implantable central venous access port was removed. <i>Corynebacterium provencense</i> was identified from two sets of blood cultures. Vancomycin treatment was continued for 14 days after port removal, and the patient was discharged home on the 47th day. Although <i>C.</i> <i>provencense</i> infection had not been previously reported in humans, it could be treated by port removal and vancomycin administration, as demonstrated in other reports on <i>Corynebacterium</i> infections.